Keywords: thalidomide, investigated, colorectal, cancer, celgene, corp, national

Thalidomide to be investigated in colorectal cancer

Article | 06 August 1999

Print This

Celgene Corp and the US National Cancer Institute have initiated aPhase II trial to evaluate Thalomid (thalidomide) in 94 patients following ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in